The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
MeSH Review

HIV Long Terminal Repeat

 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of HIV Long Terminal Repeat

 

High impact information on HIV Long Terminal Repeat

 

Biological context of HIV Long Terminal Repeat

  • In the present study, RNase protection assays were utilized to reveal the molecular mechanism(s) underlying transactivation of the HIV-1-LTR in these cells [8].
 

Associations of HIV Long Terminal Repeat with chemical compounds

 

Gene context of HIV Long Terminal Repeat

References

  1. Activation of human B-MYB by cyclins. Sala, A., Kundu, M., Casella, I., Engelhard, A., Calabretta, B., Grasso, L., Paggi, M.G., Giordano, A., Watson, R.J., Khalili, K., Peschle, C. Proc. Natl. Acad. Sci. U.S.A. (1997) [Pubmed]
  2. Evaluation of relative promoter strengths of the HIV-1-LTR and a chimeric RSV-LTR in T lymphocytic cells and peripheral blood mononuclear cells: promoters for anti-HIV-1 gene therapies. Mukhtar, M., Duan, L., Bagasra, O., Pomerantz, R.J. Gene Ther. (1996) [Pubmed]
  3. Prostratin induces HIV activation and downregulates HIV receptors in peripheral blood lymphocytes. Rullas, J., Bermejo, M., García-Pérez, J., Beltán, M., González, N., Hezareh, M., Brown, S.J., Alcamí, J. Antivir. Ther. (Lond.) (2004) [Pubmed]
  4. Mechanisms of HIV-1 inhibition by the lipid mediator N-arachidonoyldopamine. Sancho, R., de la Vega, L., Macho, A., Appendino, G., Di Marzo, V., Muñoz, E. J. Immunol. (2005) [Pubmed]
  5. Rac1 and Toll-IL-1 receptor domain-containing adapter protein mediate Toll-like receptor 4 induction of HIV-long terminal repeat. Equils, O., Madak, Z., Liu, C., Michelsen, K.S., Bulut, Y., Lu, D. J. Immunol. (2004) [Pubmed]
  6. Bacterial lipopolysaccharide activates HIV long terminal repeat through Toll-like receptor 4. Equils, O., Faure, E., Thomas, L., Bulut, Y., Trushin, S., Arditi, M. J. Immunol. (2001) [Pubmed]
  7. Interaction of HIV-1 Tat protein with heparin. Role of the backbone structure, sulfation, and size. Rusnati, M., Coltrini, D., Oreste, P., Zoppetti, G., Albini, A., Noonan, D., d'Adda di Fagagna, F., Giacca, M., Presta, M. J. Biol. Chem. (1997) [Pubmed]
  8. Mechanisms of transcriptional transactivation and restriction of human immunodeficiency virus type I replication in an astrocytic glial cell. Niikura, M., Dornadula, G., Zhang, H., Mukhtar, M., Lingxun, D., Khalili, K., Bagasra, O., Pomerantz, R.J. Oncogene (1996) [Pubmed]
  9. Hydroxyurea inhibits the transactivation of the HIV-long-terminal repeat (LTR) promoter. Calzado, M.A., MacHo, A., Lucena, C., Muñoz, E. Clin. Exp. Immunol. (2000) [Pubmed]
  10. Mesuol, a natural occurring 4-phenylcoumarin, inhibits HIV-1 replication by targeting the NF-kappaB pathway. Márquez, N., Sancho, R., Bedoya, L.M., Alcamí, J., López-Pérez, J.L., Feliciano, A.S., Fiebich, B.L., Muñoz, E. Antiviral Res. (2005) [Pubmed]
  11. Human GM-CSF induces HIV-1 LTR by multiple signalling pathways. Watanabe, S., Murakami, T., Nakamura, T., Morimoto, C., Arai, K. Biochimie (2002) [Pubmed]
  12. Activation of transcription from the human immunodeficiency virus type 1 (HIV-1) long terminal repeat by the vasoactive intestinal peptide (VIP). Gilles, A., Miquelis, A., Luis, J., Faure, E. Ital. J. Biochem. (1998) [Pubmed]
 
WikiGenes - Universities